Literature DB >> 15531659

Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease.

Timothy M Trebble1, Nigel K Arden, Stephen A Wootton, Philip C Calder, Mark A Mullee, David R Fine, Mike A Stroud.   

Abstract

BACKGROUND: Crohn disease (CD) is associated with osteoporosis and other extraintestinal manifestations that might be mediated by cytokines from circulating (peripheral blood) mononuclear cells (PBMCs). Fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces disease activity in patients with CD with raised laboratory markers of inflammation and in healthy subjects alters PBMC function.
OBJECTIVE: We investigated the effect of fish oil plus antioxidants on cytokine production by PBMCs from patients with CD with raised C-reactive protein concentrations (>/=6.9 mg/L) or erythrocyte sedimentation rates (>/=18 mm/h).
DESIGN: A randomized placebo-controlled trial of fish oil (2.7 g EPA and DHA/d; n = 31) or placebo (olive oil; n = 31) for 24 wk was conducted in patients with CD. The fish-oil group additionally received an antioxidant preparation (vitamins A, C, and E and selenium). Exclusion criteria included corticosteroid use. Fatty acid composition was measured by gas chromatography. Production of tumor necrosis factor alpha, interferon gamma (IFN-gamma), and prostaglandin E(2) (PGE(2)) was measured by enzyme-linked immunosorbent assays after stimulation with mitogen and endotoxin (lipopolysaccharide).
RESULTS: Fish-oil plus antioxidant dietary supplementation was associated with higher EPA and DHA incorporation into PBMCs (P < 0.001) and lower arachidonic acid (P = 0.006) and lower production of IFN-gamma by mitogen-stimulated PBMCs (P = 0.012) and of PGE(2) by lipopolysaccharide-stimulated PBMCs (P = 0.047).
CONCLUSION: Dietary supplementation with fish oil plus antioxidants is associated with modified PBMC composition and lower production of PGE(2) and IFN-gamma by circulating monocytes or macrophages. The response of extraintestinal manifestations of CD should be investigated in a randomized controlled trial.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531659     DOI: 10.1093/ajcn/80.5.1137

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

Review 1.  Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Authors:  Shani Dahan; Yahel Segal; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2017-04-13       Impact factor: 20.543

2.  Lemon verbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat.

Authors:  Loïc Lenoir; Adrien Rossary; Juliette Joubert-Zakeyh; Juliette Vergnaud-Gauduchon; Marie-Chantal Farges; Didier Fraisse; Odile Texier; Jean-Louis Lamaison; Marie-Paule Vasson; Catherine Felgines
Journal:  Dig Dis Sci       Date:  2011-06-18       Impact factor: 3.199

Review 3.  Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?

Authors:  Ali Rezaie; Robyn D Parker; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

4.  Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?

Authors:  Philip C Calder
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 5.  The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes.

Authors:  S C Mills; A C Windsor; S C Knight
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 6.  Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents.

Authors:  Kevin Fritsche
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

Review 7.  Preoperative optimization of crohn disease.

Authors:  Amit Sharma; Bertram T Chinn
Journal:  Clin Colon Rectal Surg       Date:  2013-06

8.  Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.

Authors:  Mojgan Masoodi; Daniel S Pearl; Michael Eiden; Janis K Shute; James F Brown; Philip C Calder; Timothy M Trebble
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

9.  Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 Response.

Authors:  Javier Rodríguez-Carrio; Mercedes Alperi-López; Patricia López; Francisco Javier Ballina-García; Ana Suárez
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 10.  Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.

Authors:  Raffi Lev-Tzion; Anne Marie Griffiths; Oren Leder; Dan Turner
Journal:  Cochrane Database Syst Rev       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.